Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock

Therapeutic Apheresis and Dialysis

Volumn 19, Issue 4, 2015, Pages 316-323

  Yamashita, Chizuru ^a   Hara, Yoshitaka ^a   Kuriyama, Naohide ^a   Nakamura, Tomoyuki ^a   Nishida, Osamu ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Direct hemoperfusion; Hemodynamics; Long duration; Polymyxin B immobilized fiber column; Pulmonary oxygenation capacity; Septic shock

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; NORADRENALIN; ANTIINFECTIVE AGENT; POLYMYXIN B;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HEMOPERFUSION; HUMAN; MAINTENANCE OF RESPIRATION AND CIRCULATION; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM PARAMETERS; PATIENT SAFETY; POLYMYXIN B IMMOBILIZED FIBER COLUMN DIRECT HEMOPERFUSION THERAPY; PRESSURE CATECHOLAMINE INDEX; PRIORITY JOURNAL; PULMONARY OXYGENATION CAPACITY; RETROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT DURATION; TREATMENT RESPONSE; AGED; APACHE; BLOOD; DEVICES; DRUG EFFECTS; LEUKOCYTE COUNT; LUNG CIRCULATION; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTOR; SEPSIS; SHOCK, SEPTIC; TIME FACTOR;

AGED; ANTI-BACTERIAL AGENTS; APACHE; FEMALE; HEMOPERFUSION; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN CONSUMPTION; POLYMYXIN B; PULMONARY CIRCULATION; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS; SHOCK, SEPTIC; TIME FACTORS;

EID: 84941889312     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12339     Document Type: Article

References (26)

1. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338:732-736.
2. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-214.
3. Dellinger RP, Levy MM, Rhodes A etal. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
4. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003;7:108-114.
5. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-417.
6. Nakamura T, Matsuda T, Suzuki Y, Shoji H, Koide H. Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial Transplant 2003;32:602-607.
7. Vincent JL, Laterre PF, Cohen J etal. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
8. Cruz DN, Antonelli M, Fumagalli R etal. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-2452.
9. Ikeda T, Ikeda K, Nagura M etal. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial 2004;8:293-298.
10. Nemoto H, Nakamoto H, Okada H etal. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361-369.
11. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
12. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD etal. Acute respiratory distress syndrome: Berlin Definition. JAMA 2012;307:2526-2533.
13. Gando S, Wada H, Asakura H etal. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 2005;11:71-76.
14. Wang Y, Liu Y, Sarker KP etal. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-155.
15. Kumagai T, Takeyama N, Yabuki T etal. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock 2010;34:461-466.
16. Tsujimoto H, Ono S, Hiraki S etal. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+14+ monocytes in patients with septic shock. J Endotoxin Res 2004;10:229-237.
17. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B immobilized fiber. Am J Surg 2004;188:150-156.
18. Kawamata T, Imaizumi H, Yoshida M, Kaneko M. Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 1997;23:130-131.
19. Tsushima K, Kubo K, Koizumi T etal. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 2002;17:97-102.
20. Mitaka C, Tsuchida N, Kawada K, Nakajima Y, Imai T, Sasaki S. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock 2009;32:478-483.
21. Suzuki H, Nemoto H, Nakamoto H etal. Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher Dial 2002;6:234-240.
22. Mitaka C, Fujiwara N, Yamamoto M, Toyofuku T, Haraguchi G, Tomita M. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period. J Crit Care 2014;29:728-732.
23. Abe S, Azuma A, Mukae H etal. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis. Intern Med 2012;51:1487-1491.
24. Kono M, Suda T, Enomoto N etal. Evaluation of different perfusion durations in direct hemoperfusion with polymyxin B-immobilized fiber column therapy for acute exacerbation of interstitial pneumonias. Blood Purif 2011;32:75-81.
25. Nishida O, Nakamura T, Kuriyama N etal. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. Contrib Nephrol 2011;173:172-181.
26. Yamato M, Minematsu Y, Fujii J etal. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial. Ther Apher Dial 2013;17:472-476.